Evaluating Community Health Centers' Adoption of a New Global Capitation Payment

NCT02637869 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400000

Last updated 2019-10-14

No results posted yet for this study

Summary

The investigators are conducting a prospective analysis of the Alternative Payment Methodology (APM) demonstration project sites. The investigators' goal is to conduct a cross project analysis of findings. The investigators propose to use mixed methods to study processes and outcomes associated with the APM natural experiment in payment reform. The investigators hypothesize that Community Health Centers (CHCs) participating in the APM demonstration project will redesign their workflows to better focus on patient and population health needs, resulting in reallocation of financial resources, lower overall costs, changes in utilization patterns, and improved quality.

Conditions

Interventions

OTHER

Alternative Payment Model

Oregon developed an Alternative Payment Methodology (APM). Under this APM pilot participating CHCs will receive a prospective payment system (PPS) payment as a capitated equivalent in a per-member-per-month rate for all of their Medicaid patients

Sponsors & Collaborators

  • OCHIN, Inc.

    collaborator OTHER
  • Robert Wood Johnson Foundation

    collaborator OTHER
  • Agency for Healthcare Research and Quality (AHRQ)

    collaborator FED
  • Oregon Health and Science University

    lead OTHER

Principal Investigators

  • John Heintzman, MD, MPH · Oregon Health and Science University

  • Heather Angier, MPH · Oregon Health and Science University

Eligibility

Min Age
2 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2020-05-31
Completion
2020-05-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02637869 on ClinicalTrials.gov